Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03600779
NA

Application of ihMT MRI in Multiple Sclerosis

Sponsor: Assistance Publique Hopitaux De Marseille

View on ClinicalTrials.gov

Summary

The development of in vivo biomarkers sensitive to myelin disruption represents a major clinical need to be able to monitor the demyelination processes as well as the effect of remyelinating therapies in multiple sclerosis. The investigators recently proposed a technique, derived from the conventional magnetisation transfer (MT): inhomogeneous Magnetisation Transfer (ihMT). In preliminary studies, this simple-to-implement and robust technique has shown great sensitivity for evaluating the demyelination processes. The goal of the project is to evaluate the ability of ihMT to measure and describe the spontaneous demyelination and remyelination processes involved in active lesions in a population of patients with MS at the the disease onset.

Official title: Application of the Inhomogeneous Magnetisation Transfer MRI (ihMT) Technique, a New Myelin-specific MRI Technique, in Multiple Sclerosis

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

85

Start Date

2018-06-14

Completion Date

2027-02-13

Last Updated

2024-08-06

Healthy Volunteers

Yes

Interventions

DEVICE

inhomogeneous Magnetisation Transfer (ihMT) sequence

robust technique has shown great sensitivity for evaluating the demyelination processes using MRI at 1.5T

DEVICE

inhomogeneous Magnetisation Transfer (ihMT) sequence at 3T

robust technique has shown great sensitivity for evaluating the demyelination processes using MRI at 3T

Locations (1)

Assistance Publique Des Hotipaux de Marseille

Marseille, PACA, France